Mercury Fund — 2020 Investments
4 investments dated 2020 · listed companies and verified rows first · show all
Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
BiotechDeep TechDigital HealthMedical DevicesWatertown, US
Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)Kari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)
BoardKristina Burow(Director)in
Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalK2 HealthVenturesPremier PartnersSoftBank Vision Fund+1 more
Aclaimant provides risk management software to help organizations identify and actively manage business risks.
Enterprise SoftwareInsurTechChicago, US
Michael Schultz(Co-founder)David Wald(Executive Officer, Director)inJim Farber(Founder)
BoardLaura Brady(Director)
Board seatAdrian Fortino· per SEC Form D
Co-investorsLightbankModerne VenturesNext Coast VenturesRoyal Street Ventures Management Company, LlcRRE VenturesUrban Capital Network
Cabin John, US
Andrew Mignatti(Executive Officer, Director)Pericles Dimas(Executive Officer, Director)
Board seatAziz Gilani· per SEC Form D · $6.7M raise · filed Apr 2020
Vancouver
DARRYL CARDEY(Director)MARK LOTZ(Executive Officer)EDDIE SHEK(Executive Officer)ROBB JAMES(Executive Officer, Director)DARREN DEVIN(Executive Officer, Director)TIM HARVIE(Executive Officer, Director)
Board seatHeath ButlerBlair Garrou· per SEC Form D · $207K raise · filed Jan 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.